{"id":"W3007752132","doi":"10.1182/bloodadvances.2019000885","title":"A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Edoxaban; Medicine; Anticoagulant; Bolus (digestion); Apixaban; Placebo; Pharmacology; Anesthesia; Internal medicine; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001985164,0.002369936,0.003184442,0.0005237715,0.0004701465,0.001411249,0.0008197637,0.001917374,0.003048334],"category_scores_gemma":[0.002099586,0.0009757822,0.001721475,0.0003907884,0.001021615,0.001285503,0.0004205512,0.00304483,0.000761332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000678983,"about_ca_system_score_gemma":0.001751996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006165921,"about_ca_topic_score_gemma":0.001022412,"domain_scores_codex":[0.9992816,0.0003044117,0.00003463711,0.0001920442,0.00006722858,0.0001200806],"domain_scores_gemma":[0.9991592,0.0001432817,0.0001672877,0.0001141475,0.00008683196,0.0003292635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8218874,0.06809399,0.001436293,0.0006178804,0.001213755,0.000318825,0.0002210284,0.001210015,0.05278553,0.0002440237,0.002320228,0.04965108],"study_design_scores_gemma":[0.5658473,0.4197095,0.003874307,0.00002845608,0.0005324153,0.0003761123,0.00003969805,0.001143995,0.004878847,0.0002566607,0.003257479,0.00005526507],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876924,0.002804792,0.002159773,0.0004336829,0.0002500458,0.004140161,0.0009995918,0.0002036321,0.001315839],"genre_scores_gemma":[0.9796194,0.002669272,0.004961323,0.001490836,0.0003576504,0.005199016,0.002240815,0.00007215272,0.003389494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003184442,"threshold_uncertainty_score":0.01049864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07116701488639715,"score_gpt":0.3844771447968021,"score_spread":0.3133101299104049,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}